FIELD: medicine.
SUBSTANCE: euphylline, trental, nicotinic acid, ascorbic acid, B1 and B6 group vitamins are administered intravenously; papaverine and dibazol are injected intramuscularly in standard doses and combined with intravenous injections of tompasline in an amount of 40 mg daily for 10 days.
EFFECT: method enables increasing the clinical effectiveness and reducing the length of treatment accompanied by hearing recovery and no side effects.
3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR THE TREATMENT OF ACUTE ACOUSTIC INJURY | 2022 |
|
RU2783255C1 |
| AGENT FOR TREATMENT OF PATIENTS WITH ACUTE AND SUDDEN SENSONEURAL DIMINISHED HEARING AND DEAFNESS | 1997 |
|
RU2119335C1 |
| METHOD FOR PREDICTION OF HEARING RESTORATION IN PATIENTS WITH ACUTE SENSORINEURAL HEARING LOSS | 2013 |
|
RU2545744C1 |
| METHOD FOR SURGICAL TREATMENT OF CHRONIC SECONDARY SENSONEURAL DEAFNESS | 2016 |
|
RU2651110C1 |
| METHOD FOR TREATING NEUROSENSORY HYPOACUSIA | 2001 |
|
RU2188642C1 |
| METHOD OF EARLY EXTENDED AUDIOLOGIC DIAGNOSTICS OF AUDITORY DISORDERS, CAUSED BY DISSEMINATED SCLEROSIS | 2007 |
|
RU2374983C2 |
| METHOD FOR AUDITARY INEFFICIENCY REHABILITATION IN PATIENTS | 2017 |
|
RU2637291C1 |
| METHOD FOR PREDICTION OF SURGICAL OUTCOME OF NON-INFLAMMATORY PERILYMPHATIC FISTULAS OF LABYRINTH WINDOWS | 2020 |
|
RU2737715C1 |
| AGENT AND METHOD FOR TREATING SENSORINEURAL HEARING LOSS | 2018 |
|
RU2698451C1 |
| METHOD FOR EVALUATING RESTORED AUDITORY FUNCTION IN ACUTE PERIOD OF SENSONEURAL IMPAIRED HEARING | 2002 |
|
RU2224256C2 |
